Highlights
- 1Translational research : the journal of laboratory and clinical medicine · 2020
- 2Clinical and experimental immunology · 2020
- 3
Publications
325 publications
Funding
9 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- Sub-PICardiovascular Risk of Antiretroviral Therapy Drugs in HIVNational Heart, Lung, and Blood Institute · 2023–2027 · via Oklahoma Medical Research FoundationR01HL167656-04
- PIRole of MASP-2 in microvascular endothelial cell injury associated with severe COVID-19 and all HSCT-TMAsOmeros Corporation · 2021–2025ContractSRA 211471-01
Completed grants (7)
- PIDefibrotide in endothelial cell injury and platelet activation syndromesJazz Pharmaceuticals, Inc. · 2021–2023ContractSRA 220298-01
- PIDecision tree analysis to determine optimal treatment duration in aHUSAlexion Pharmaceuticals, Inc. · 2021–2023ContractSRA 210243-01
- PIRole of defibrotide in modulating platelet reactivity and EC injury induced by TTP and aHUS-type TMA patient plasmas: correlation of in vitro assays with in vivo biomarkers.Jazz Pharmaceuticals, Inc. · 2020–2021ContractSRA 203093-01
- PIRole of defibrotide in modulating microvascular endothelial cell pathology induced by plasmas from patients with primary and secondary thrombotic microangiopathiesJazz Pharmaceuticals · 2018–2019ContractSRA 170407-01
- PIMechanisms of HIV/ART Related Cardiac FibrosisNational Heart, Lung, and Blood Institute · 2014–2017
- PIMolecular basis for HIV therapy-linked osteopeniaNIDDK · 2005–2011 · via NIH RePORTERR01DK065511-04
Honors & distinctions
1 honor
- Member · American Society for Clinical Investigation · 1997
Clinical research
1 study
Completed & closed trials (1)
- PIDecision Tree Analysis to Determine Optimal Treatment Duration in Atypical Hemolytic Uremic Syndrome (aHUS)Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2024)
News mentions
2 mentionsView all WCM news ↗
- COVID-19, Vaccines and Abnormal Blood ClottingApril 15, 2021
Hematology and oncology specialist Dr. Jeffrey Laurence answers questions about the connection between blood clotting, COVID-19 and vaccines.
- What Is Known About COVID-19 and Abnormal Blood ClottingJuly 2, 2020
Hematology and oncology specialist Dr. Jeffrey Laurence answers questions about the connection between blood clotting and other symptoms of severe COVID-19.
External relationships
Advisory/Scientific Board Member
Novartis Pharmaceuticals Corporation
Speaker/Lecturer
Alexion Pharmaceuticals, Inc.
Other Interest
Novartis Pharmaceuticals Corporation
Other
Foundation for AIDS Research (amfAR), The · Sanofi S.A.